Prognosis
Astra’s Endorsement in EU Isn’t Good Enough for Nordics
The Pfizer-BioNTech, Moderna and AstraZeneca Covid-19 vaccines at Skane University Hospital vaccination centre, Malmo.
Photographer: Johan Nilsson/AFP/Getty Images
This article is for subscribers only.
The European Medicines Agency’s assertion that AstraZeneca Plc’s vaccine is safe and effective fell flat in the Nordic region, where countries are keeping the company on hold until local authorities complete their own reviews.
Sweden, Denmark and Norway put out statements shortly after the EMA’s reassurances were made public late on Thursday. By Friday afternoon, Finland had joined the group as it investigated two cases of blood clots. All four said they expect to make a decision next week, pending the outcome of national reviews of Astra’s vaccine.